Lupin, Sun Pharma and Jubilant Cadista recall drugs in US market A class II recall is initiated in a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences
Leading generic drug makers Lupin, Sun Pharma and Jubilant Cadista are recalling different products in the US, the world’s largest market for medicines, for different reasons.
According to the latest enforcement report by the US Food and Drug Administration (USFDA), the US-based unit of Lupin is recalling 17,814 bottles of Cefprozil for Oral Suspension USP, a second-generation antibiotic used to treat infections of the ear, skin and other bacterial infections.
Lupin, Sun Pharma, Jubilant Cadista recall drugs in US market indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.
Sun Pharma recalls 36,275 cartons of testosterone injection in US
As per the USFDA report, the affected lot of the intramuscular injections was manufactured by the drug maker in India and distributed in the US by Princeton, New Jersey-based Sun Pharmaceutical Industries Inc.
BusinessToday.In | February 7, 2021 | Updated 16:35 IST
Sun Pharmaceutical Industries is recalling 36,275 cartons of Testosterone Cypionate Injection
Pharma major Sun Pharmaceutical Industries is recalling 36,275 cartons of a drug used to treat low testosterone levels in the US market for incorrect labelling. The Testosterone Cypionate Injection is being recalled in the American market by the US arm of Sun Pharma, as per the latest enforcement report of the US Food and Drug Administration. The company started the nationwide recall on January 11, 2021.